These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
144 related articles for article (PubMed ID: 10926829)
1. Effects of modification of the hydrophobic C-1-C-16 segment of tautomycin on its affinity to type-1 and type-2A protein phosphatases. Takai A; Tsuboi K; Koyasu M; Isobe M Biochem J; 2000 Aug; 350 Pt 1(Pt 1):81-8. PubMed ID: 10926829 [TBL] [Abstract][Full Text] [Related]
2. Differential inhibition and posttranslational modification of protein phosphatase 1 and 2A in MCF7 cells treated with calyculin-A, okadaic acid, and tautomycin. Favre B; Turowski P; Hemmings BA J Biol Chem; 1997 May; 272(21):13856-63. PubMed ID: 9153244 [TBL] [Abstract][Full Text] [Related]
3. Characterization of natural toxins with inhibitory activity against serine/threonine protein phosphatases. Honkanen RE; Codispoti BA; Tse K; Boynton AL; Honkanan RE Toxicon; 1994 Mar; 32(3):339-50. PubMed ID: 8016855 [TBL] [Abstract][Full Text] [Related]
4. Inhibition of specific binding of okadaic acid to protein phosphatase 2A by microcystin-LR, calyculin-A and tautomycin: method of analysis of interactions of tight-binding ligands with target protein. Takai A; Sasaki K; Nagai H; Mieskes G; Isobe M; Isono K; Yasumoto T Biochem J; 1995 Mar; 306 ( Pt 3)(Pt 3):657-65. PubMed ID: 7702557 [TBL] [Abstract][Full Text] [Related]
5. Effect of inhibitors of protein phosphatase 1 and 2A on erythroid colony formation: an investigation of the specificities of inhibitors. Zhang W; Tamura J; Sakuraya M; Naruse T; Kubota K J Int Med Res; 2001; 29(2):114-8. PubMed ID: 11393344 [TBL] [Abstract][Full Text] [Related]
6. The apoptosis-inducing activity of the two protein phosphatase inhibitors, tautomycin and thyrsiferyl 23-acetate, is not due to the inhibition of protein phosphatases PP1 and PP2A (review). Kikuchi K; Shima H; Mitsuhashi S; Suzuki M; Oikawa H Int J Mol Med; 1999 Oct; 4(4):395-401. PubMed ID: 10493981 [TBL] [Abstract][Full Text] [Related]
7. Role of protein phosphatases in cyclic AMP-mediated stimulation of hepatic Na+/taurocholate cotransport. Mukhopadhyay S; Webster CR; Anwer MS J Biol Chem; 1998 Nov; 273(45):30039-45. PubMed ID: 9792726 [TBL] [Abstract][Full Text] [Related]
8. Use of penetrating peptides interacting with PP1/PP2A proteins as a general approach for a drug phosphatase technology. Guergnon J; Dessauge F; Dominguez V; Viallet J; Bonnefoy S; Yuste VJ; Mercereau-Puijalon O; Cayla X; Rebollo A; Susin SA; Bost PE; Garcia A Mol Pharmacol; 2006 Apr; 69(4):1115-24. PubMed ID: 16387795 [TBL] [Abstract][Full Text] [Related]
9. Identification of protein phosphatase 2C and confirmation of other protein phosphatases in the ocular lenses. Umeda IO; Nakata H; Nishigori H Exp Eye Res; 2004 Dec; 79(6):385-92. PubMed ID: 15669140 [TBL] [Abstract][Full Text] [Related]
10. Tautomycin's interactions with protein phosphatase 1. Sydnes MO; Isobe M Chem Asian J; 2010 Mar; 5(3):410-20. PubMed ID: 20013999 [TBL] [Abstract][Full Text] [Related]
11. Importance of the beta12-beta13 loop in protein phosphatase-1 catalytic subunit for inhibition by toxins and mammalian protein inhibitors. Connor JH; Kleeman T; Barik S; Honkanen RE; Shenolikar S J Biol Chem; 1999 Aug; 274(32):22366-72. PubMed ID: 10428807 [TBL] [Abstract][Full Text] [Related]
12. Inhibitory effect of okadaic acid derivatives on protein phosphatases. A study on structure-affinity relationship. Takai A; Murata M; Torigoe K; Isobe M; Mieskes G; Yasumoto T Biochem J; 1992 Jun; 284 ( Pt 2)(Pt 2):539-44. PubMed ID: 1318034 [TBL] [Abstract][Full Text] [Related]
13. Tautomycetin is a novel and specific inhibitor of serine/threonine protein phosphatase type 1, PP1. Mitsuhashi S; Matsuura N; Ubukata M; Oikawa H; Shima H; Kikuchi K Biochem Biophys Res Commun; 2001 Sep; 287(2):328-31. PubMed ID: 11554729 [TBL] [Abstract][Full Text] [Related]
14. Phospholipase C-related but catalytically inactive protein, PRIP as a scaffolding protein for phospho-regulation. Sugiyama G; Takeuchi H; Kanematsu T; Gao J; Matsuda M; Hirata M Adv Biol Regul; 2013 Sep; 53(3):331-40. PubMed ID: 23911386 [TBL] [Abstract][Full Text] [Related]
15. Regulation of choline transporter surface expression and phosphorylation by protein kinase C and protein phosphatase 1/2A. Gates J; Ferguson SM; Blakely RD; Apparsundaram S J Pharmacol Exp Ther; 2004 Aug; 310(2):536-45. PubMed ID: 15064333 [TBL] [Abstract][Full Text] [Related]
16. Regional expression of protein phosphatase type 1 and 2A catalytic subunit isoforms in the human heart. Lüss H; Klein-Wiele O; Bokník P; Herzig S; Knapp J; Linck B; Müller FU; Scheld HH; Schmid C; Schmitz W; Neumann J J Mol Cell Cardiol; 2000 Dec; 32(12):2349-59. PubMed ID: 11113010 [TBL] [Abstract][Full Text] [Related]
17. Regulation of thromboxane receptor (TP) phosphorylation by protein phosphatase 1 (PP1) and PP2A. Spurney RF J Pharmacol Exp Ther; 2001 Feb; 296(2):592-9. PubMed ID: 11160648 [TBL] [Abstract][Full Text] [Related]
18. Usage of tautomycetin, a novel inhibitor of protein phosphatase 1 (PP1), reveals that PP1 is a positive regulator of Raf-1 in vivo. Mitsuhashi S; Shima H; Tanuma N; Matsuura N; Takekawa M; Urano T; Kataoka T; Ubukata M; Kikuchi K J Biol Chem; 2003 Jan; 278(1):82-8. PubMed ID: 12374792 [TBL] [Abstract][Full Text] [Related]
19. Reduced expression of the regulatory A subunit of serine/threonine protein phosphatase 2A in human breast cancer MCF-7 cells. Suzuki K; Takahashi K Int J Oncol; 2003 Nov; 23(5):1263-8. PubMed ID: 14532964 [TBL] [Abstract][Full Text] [Related]
20. Gene cloning and expression and characterization of a toxin-sensitive protein phosphatase from the methanogenic archaeon Methanosarcina thermophila TM-1. Solow B; Young JC; Kennelly PJ J Bacteriol; 1997 Aug; 179(16):5072-5. PubMed ID: 9260948 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]